Sort
16,179 grants matching “malaria”
Malaria Epidemiology and Vector Biology of Anopheles stephensi across Rural and Urban Landscapes in Ethiopia
$932,408Guiyun Yan · University Of California-Irvine · U19 · FY2024 · AI
SCH: INT: Surveillance and Control of Mosquito-Borne Diseases through Automated Species Identification and Spatiotemporal Modeling
$932,000Ryan M Carney · University Of South Florida · · FY2020 · CSE
Odorprint Based Disease Diagnostics
$931,815Dmitry Rinberg · New York University School Of Medicine · R01 · FY2023 · DC
PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response.
$931,246Iain James Macleod · Aldatu Biosciences, Inc. · R44 · FY2023 · AI
Optimizing HIV-malaria treatment in a shifting treatment and resistance landscape in Africa
$930,846Sunil Parikh · Yale University · R01 · FY2024 · HD
HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
$929,677Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
TH2 BIAS EFFECT ON MALARIAL IMMUNITY IN CAMEROON
$928,928Georgetown University · U01 · FY2001 · AI
Malaria Drug Resistance and Disease Virulence
$927,613Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Structural vaccinology for infectious diseases
$927,506Niraj Tolia · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
TH2 BIAS EFFECT ON MALARIAL IMMUNITY IN CAMEROON
$926,546Georgetown University · U01 · FY2002 · AI
Institutional Collaboration between LSTM and CDC and Prevention on Malaria(U01)
$925,450Feiko Olaf Ter Kuile · Tmliverpool School Of Tropical Medicine · U01 · FY2013 · CK
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.
$925,300Nhi Khuong · Lumen Bioscience, Inc. · R42 · FY2024 · AI
Genomic Studies of the Impact of External Factors on Parasite Development and Disease Outcome
$924,968Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2021 · AI
Optimized Combination Antimalarial Drug Therapy
$923,203Paul D. Roepe · Georgetown University · R01 · FY2018 · AI
Optimized Combination Antimalarial Drug Therapy
$923,203Paul D. Roepe · Georgetown University · R01 · FY2016 · AI
Optimized Combination Antimalarial Drug Therapy
$923,203Paul D. Roepe · Georgetown University · R01 · FY2017 · AI
Malaria Parasite Ligands And Host Cell Receptors
$922,609Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Mosquito Immune Responses and Malaria Transmission
$921,863Carolina Barillas-Mury · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)
$920,583Robert Harper · Analytical Diagnostic Solutions, Inc. · SB1 · FY2022 · AI
Core 2: BSL-3 Practices Core
$920,265Scott Alderman · Duke University · UC7 · FY2023 · AI
Human B Cell Responses to Malaria Vaccination and Infection
$920,156Susan Pierce · Niaid Extramural Activities · Z01 · FY2007 · AI
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
$920,087Sanjay Rajagopalan · Case Western Reserve University · R35 · FY2025 · ES
Development of Malaria Transmission-Blocking Drugs
$920,000Wenwei Huang · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Clinical Studies of Interactions Between HIV and Malaria
$919,923Diane V Havlir · University Of California, San Francisco · U01 · FY2006 · AI
Odorprint Based Disease Diagnostics
$918,295Dmitry Rinberg · New York University School Of Medicine · R01 · FY2024 · DC